1/ Our contribution to drug repositioning (DR) for metabolic disease (MD)
In HUMANS Insulin resistance (IR) in muscle & adipose shares COMMON molecular pathways & COMMON treatment responses (n= >2,000 samples). @mackinprof @eLIFE @JPTK_TechBio @chvolmar
doi.org/10.7554/eLife.…
2/ Using the common molecular features from muscle & adipose we built a 120-gene RNA IR assay & found this multi-gene assay could rank families of active drugs by potency #novel Active drugs have many protein targets #not-novel
@mackinprof @eLIFE
doi.org/10.7554/eLife.…
3/ The assay identified >200 +ve & -ve acting drugs – many proven to improve or impair insulin signalling. Not all +ve drugs will be safe to explore further but many had efficacy in recent MD models @mackinprof @eLIFE
doi.org/10.7554/eLife.…
4) #DeepLearning models helped explore kinase inhibitor specificity and compensate for lack of in vitro potency data, when exploring mechanism of action and off-target activities
@mackinprof @eLIFE @JPTK_TechBio
doi.org/10.7554/eLife.…
5) The assay selected a range of inhibitors e.g. glucosylceramide synthase @StephenORahilly 2007, and Nifedipine Sheu 1991, Visfatin Lockman 2010 & many that emerged & cited during our project. Old Science & Replication is GRRRRREAT.
@mackinprof @eLIFE
doi.org/10.7554/eLife.…
6/ The 120-gene assay allowed us to link active drug targets to disease pathways. Notably protein targets of active drugs connect at PATHWAY level, but they are NOT usually the differentially regulated gene biomarkers #Novel #Repurpose
@mackinprof @eLIFE
doi.org/10.7554/eLife.…
7) Information from the dual-tissue exercise-treatment signature improved the performance of fasting disease signature alone #L1000
MD GWAS derived gene lists were NOT useful at all in this DR project
@mackinprof @eLIFE @chvolmar
doi.org/10.7554/eLife.…
8/ Are the drugs mimicking ‘exercise’? Not ‘exercise in a pill’ – but they may have potential to enhance some responses to exercise
Notably +ve drugs seem to target PROXIMAL aspects of insulin signalling not distal targets
@mackinprof @eLIFE
doi.org/10.7554/eLife.…
9) This assay is for drugs that reverse HOMA2-IR; other aspects of insulin sig to be incorporated + need to better understand nuclear receptor activity in assay in vitro setting
@mackinprof @eLIFE
doi.org/10.7554/eLife.…
10) QED - Bulk transcriptomics can define metabolic disease & design IR drug repositioning assays. Unlike Aussie mice, human adipose & muscle share COMMON IR pathways & treatment responses, including proteins causally regulating IR
@mackinprof @eLIFE
doi.org/10.7554/eLife.…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Jamie Timmons

Jamie Timmons Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(